---
title: "Gilead Sciences (GILD) stock analysis"
url: https://portfolio-terminal.com/analyse/gild
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: GILD
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Gilead Sciences (GILD) stock analysis

> **Source:** Portfolio Terminal, "Gilead Sciences (GILD) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/gild
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Gilead Sciences (GILD) trades at $151.28, up 34.3% over the past year.
- Its 52-week range runs from $108.46 to $157.29; the price is 3.8% below that high.
- It sits 11.0% above its 200-day average of $136.31, the usual sign of a long-term uptrend.
- Its 30-day volatility is 19.9% annualized, which we rate medium risk.
- It has a dividend yield of 2.15%.

## About Gilead Sciences

Gilead Sciences (GILD) is a healthcare company operating in drug manufacturers—general. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

## What the chart is saying

In an uptrend, 3.8% under its 1-year high with no resistance above.

- Price is 6.4% above its 50-day average and 11.0% above its 200-day.
- The 50-day crossed above the 200-day on 2026-08-27 (a “golden cross”).
- RSI at 59 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $142.99 (-5.5%).

### Support and resistance

- Support near $142.99, 5.5% below the last close (the price turned there 5 times in the last year).
- Support near $137.29, 9.2% below the last close (the price turned there 5 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/gild